These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 31619894

  • 1. Treatment of Xanthelasma Palpebrarum using Pulsed Dye Laser: Original Report on 14 Cases.
    Thajudheen CP, Jyothy K, Arul P.
    J Cutan Aesthet Surg; 2019; 12(3):193-195. PubMed ID: 31619894
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ultrapulse carbon dioxide laser ablation of xanthelasma palpebrarum: a case series.
    Pathania V, Chatterjee M.
    J Cutan Aesthet Surg; 2015; 8(1):46-9. PubMed ID: 25949023
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of 1,444nm Nd:YAG laser for xanthelasma palpebrarum.
    Park JH, Ryu SI, Kim IH.
    J Cosmet Laser Ther; 2020 Apr 02; 22(3):141-145. PubMed ID: 32436411
    [Abstract] [Full Text] [Related]

  • 7. Treatment of xanthelasma palpebrarum with the pulsed dye laser.
    Schönermark MP, Raulin C.
    Lasers Surg Med; 1996 Apr 02; 19(3):336-9. PubMed ID: 8923429
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of efficacy and tolerability of different concentrations of trichloroacetic acid vs. carbon dioxide laser in treatment of xanthelasma palpebrarum.
    Mourad B, Elgarhy LH, Ellakkawy HA, Elmahdy N.
    J Cosmet Dermatol; 2015 Sep 02; 14(3):209-15. PubMed ID: 26251333
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    Al Aboud AM, Shah SS, Blair K, Al Aboud DM.
    ; 2024 01 02. PubMed ID: 30285396
    [Abstract] [Full Text] [Related]

  • 12. A Clinical and Dermatoscopic Perspective of the Efficacy and Safety of Erbium: YAG Laser Ablation Versus 50% Trichloroacetic Acid for the Management of Xanthelasma Palpebrarum.
    Arora A, Mohta A, Mehta RD, Ghiya BC, Soni P, Jangir VK, Yadav MK, Khokhar R, Mangava V.
    J Cutan Aesthet Surg; 2024 01 02; 17(1):1-6. PubMed ID: 38736854
    [Abstract] [Full Text] [Related]

  • 13. Treatment of xanthelasma palpebrarum with a 1064-nm, Q-switched Nd:YAG laser.
    Heng JK, Chua SH, Goh CL, Cheng S, Tan V, Tan WP.
    J Am Acad Dermatol; 2017 Oct 02; 77(4):728-734. PubMed ID: 28666611
    [Abstract] [Full Text] [Related]

  • 14. Fractional CO2 laser versus trichloroacetic acid 50% for xanthelasma palpebrarum therapy.
    Al-Kady NA, Hamdino M, Abdel Kawy FAW.
    J Cosmet Dermatol; 2021 Mar 02; 20(3):763-768. PubMed ID: 32892481
    [Abstract] [Full Text] [Related]

  • 15. Treatment of xanthelasma palpebrarum with argon laser photocoagulation. Argon laser and xanthelasma palpebrarum.
    Basar E, Oguz H, Ozdemir H, Ozkan S, Uslu H.
    Int Ophthalmol; 2004 Jan 02; 25(1):9-11. PubMed ID: 15085969
    [Abstract] [Full Text] [Related]

  • 16. A Practical Review of the Management of Xanthelasma palpebrarum.
    Malekzadeh H, Ormseth B, Janis JE.
    Plast Reconstr Surg Glob Open; 2023 May 02; 11(5):e4982. PubMed ID: 37235133
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.